Interleukin-1 family cytokines in liver cell death: a new therapeutic target for liver diseases

Udomsinprasert, Wanvisa

doi:10.1080/14728222.2023.2285763

Cited by 2 publications

(1 citation statement)

References 185 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hepatocellular death is a fundamental biological process that regulates the progression of liver disease via distinct mechanisms. The involvement of the IL-1 family in liver cell apoptosis has been widely reported[ 44 ]. Promoting new and innovative management approaches pertaining to liver diseases through close collaboration between fundamental and clinical scientists should provide a comprehensive understanding of the complex processes involved in the contribution of the IL-1 family of cytokines to hepatocellular apoptosis[ 44 ].…”

Section: Comorbidity Impact On Il-mediated Therapy In Liver Diseasesmentioning

confidence: 99%

Interleukin-mediated therapies in liver diseases and comorbidity effects

Bouare,

Delwaide

2024

World J Hepatol

View full text Add to dashboard Cite

Cytokines like interleukins (ILs) play important roles in inflammation and innate immune. Yang and Zhang carried out an interesting study related to ILs and hepatic diseases. They described the role of ILs in the pathogenesis and resolution of hepatic disorders. The authors summarized alcohol-related liver disease and virus-induced hepatitis, as far as clinical studies a fortiori carried out on IL-mediated treatments pertaining to these dysfunctions. This editorial contributes to the review by Yang and Zhang titled, "Interleukins in liver disease treatment", and focuses on therapies mediated by ILs in comorbid liver diseases. The documentary search was conducted on recent pertinent literature, primarily using the Google Scholar and PubMed databases.

show abstract

Section: Comorbidity Impact On Il-mediated Therapy In Liver Diseasesmentioning

confidence: 99%